跳转至内容
Merck
CN

HPLC Analysis of Z-Drugs on Ascentis® Express C18 2.0 μm

HPLC Analysis of Z-Drugs on Ascentis® Express C18 2.0 μm application for HPLC

材料

相关产品

产品编号
说明
价格

扎来普隆标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

唑吡坦苯基-4-羧酸 溶液

500 μg/mL in acetonitrile: water (1:1), ampule of 1 mL, certified reference material, Cerilliant®

Ascentis® Express C18, 2 μm UHPLC 色谱柱

2 μm particle size, L × I.D. 10 cm × 3 mm

CONDITIONS

column

Ascentis Express C18, 10 cm x 3.0 mm I.D., 2.0 μm particles (50819-U)

mobile phase

[A] 10 mM ammonium formate pH 3.0 with formic acid in 90:10, water:acetonitrile; [B] 10 mM ammonium formate pH 3.0 with formic acid in 10:90, water:acetonitrile;

gradient

0 to 100% B in 3.0 min; held at 100% B for 0.5 min

flow rate

0.6 mL/min

pressure

5405 psi (373 bar)

column temp.

30 °C

detector

MS, ESI+, combined SIR

injection

0.5 μL

sample

10 μg/mL in 96:4, water:methanol

说明

分析说明

An rapid method for the simultaneous determination of the Z-drugs or sleep aids: zopiclone, zolpidem, and zaleplon is presented here. The need for greater analytical capacity and throughput for the analysis of sleep aid medicines (Z-drugs) in forensic toxicology laboratories can be met by the use of fast Ascentis Express 2.0 micron Fused Core UHPLC Columns.

法律信息

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany